ISPOR Europe 2026
Workshop Access and Pricing track
Reading Between the Endpoints: Translating Trials from Regulatory Estimands to HTA/JCA Decision Making
Mon, Nov 9, 2026 · 1:45–2:45 PM CET Hall F2, Level 0, Austria Center Vienna
About this session
Purpose Estimands are now firmly embedded in regulatory guidance and are gaining prominence in HTA, with formal relevance under the EU JCA. Despite this shared framework, challenges remain in translating trial results across decision contexts.
Speakers
-
AstraZeneca
Moderator
-
UMIT TIROL - University for Health Sciences and Technology; Harvard Chan School of Public Health
Speaker
-
Astellas Pharma Ltd
Speaker
-
European Medicines Agency
Speaker